SE0100344D0 - New Use - Google Patents

New Use

Info

Publication number
SE0100344D0
SE0100344D0 SE0100344A SE0100344A SE0100344D0 SE 0100344 D0 SE0100344 D0 SE 0100344D0 SE 0100344 A SE0100344 A SE 0100344A SE 0100344 A SE0100344 A SE 0100344A SE 0100344 D0 SE0100344 D0 SE 0100344D0
Authority
SE
Sweden
Prior art keywords
substituted
straight
branched alkyl
groups
alkyl group
Prior art date
Application number
SE0100344A
Other languages
English (en)
Inventor
Jan Nordmark
Original Assignee
Jan Nordmark
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jan Nordmark filed Critical Jan Nordmark
Priority to SE0100344A priority Critical patent/SE0100344D0/sv
Publication of SE0100344D0 publication Critical patent/SE0100344D0/sv
Priority to CNB028045661A priority patent/CN100379411C/zh
Priority to PCT/SE2002/000196 priority patent/WO2002062328A1/en
Priority to DE60208347T priority patent/DE60208347T2/de
Priority to AU2002228561A priority patent/AU2002228561B2/en
Priority to JP2002562335A priority patent/JP2004522753A/ja
Priority to AT02710627T priority patent/ATE314059T1/de
Priority to US10/467,076 priority patent/US20040116535A1/en
Priority to CA002436490A priority patent/CA2436490A1/en
Priority to EP02710627A priority patent/EP1365757B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE0100344A 2001-02-05 2001-02-05 New Use SE0100344D0 (sv)

Priority Applications (10)

Application Number Priority Date Filing Date Title
SE0100344A SE0100344D0 (sv) 2001-02-05 2001-02-05 New Use
CNB028045661A CN100379411C (zh) 2001-02-05 2002-02-05 二甲基苯氧基烷胺用于制备抗耳鸣药物的用途
PCT/SE2002/000196 WO2002062328A1 (en) 2001-02-05 2002-02-05 New use
DE60208347T DE60208347T2 (de) 2001-02-05 2002-02-05 Verwendung von "xylyloxy alkyl amines" für die Behandlung von Tinnitus
AU2002228561A AU2002228561B2 (en) 2001-02-05 2002-02-05 New use
JP2002562335A JP2004522753A (ja) 2001-02-05 2002-02-05 新規用途
AT02710627T ATE314059T1 (de) 2001-02-05 2002-02-05 VERWENDUNG VON ßXYLYLOXY ALKYL AMINESß FÜR DIE BEHANDLUNG VON TINNITUS
US10/467,076 US20040116535A1 (en) 2001-02-05 2002-02-05 Use
CA002436490A CA2436490A1 (en) 2001-02-05 2002-02-05 Use of xylyloxy alkyl amines in the treatment of tinnitus
EP02710627A EP1365757B1 (en) 2001-02-05 2002-02-05 Use of xylyloxy alkyl amines for treating tinnitus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0100344A SE0100344D0 (sv) 2001-02-05 2001-02-05 New Use

Publications (1)

Publication Number Publication Date
SE0100344D0 true SE0100344D0 (sv) 2001-02-05

Family

ID=20282842

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0100344A SE0100344D0 (sv) 2001-02-05 2001-02-05 New Use

Country Status (10)

Country Link
US (1) US20040116535A1 (sv)
EP (1) EP1365757B1 (sv)
JP (1) JP2004522753A (sv)
CN (1) CN100379411C (sv)
AT (1) ATE314059T1 (sv)
AU (1) AU2002228561B2 (sv)
CA (1) CA2436490A1 (sv)
DE (1) DE60208347T2 (sv)
SE (1) SE0100344D0 (sv)
WO (1) WO2002062328A1 (sv)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2667587A1 (en) * 2006-10-27 2008-05-22 Janssen Pharmaceuticals, N.V. Methods for treatment of cochlear and vestibular disorders
US12117453B2 (en) 2018-12-07 2024-10-15 Washington University Predicting patient response to sodium channel blockers

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1643240A1 (de) * 1966-09-16 1971-06-24 Boehringer Sohn Ingelheim Verfahren zur Herstellung neuer racemischer oder optisch aktiver 1-Phenoxy-2-aminoalkane
TW450807B (en) * 1995-09-15 2001-08-21 Pfizer Pharmaceutical compositions for treating tinnitus comprising neuroprotective agents

Also Published As

Publication number Publication date
JP2004522753A (ja) 2004-07-29
DE60208347D1 (de) 2006-02-02
US20040116535A1 (en) 2004-06-17
CN100379411C (zh) 2008-04-09
DE60208347T2 (de) 2006-08-31
EP1365757B1 (en) 2005-12-28
CN1491107A (zh) 2004-04-21
ATE314059T1 (de) 2006-01-15
CA2436490A1 (en) 2002-08-15
AU2002228561B2 (en) 2006-10-05
WO2002062328A1 (en) 2002-08-15
EP1365757A1 (en) 2003-12-03

Similar Documents

Publication Publication Date Title
DK1678166T3 (da) Proteinkinaseinhibitorer
NL300877I2 (nl) obeticholzuur
BR0317435A (pt) Derivados de pirimidina para o tratamento do crescimento celular anormal
EA200970461A1 (ru) ЗАМЕЩЕННЫЕ ПРОИЗВОДНЫЕ 3-ИЗОБУТИЛ-9,10-ДИМЕТОКСИ-1,3,4,6,7,11b-ГЕКСАГИДРО-2Н-ПИРИДО[2,1-a]ИЗОХИНОЛИН-2-ОЛА И СВЯЗАННЫЕ С НИМИ СПОСОБЫ
EA200300354A1 (ru) Хинолиноновые производные в качестве ингибиторов тирозинкиназы
UY25679A1 (es) Derivados de quinolin-2-ona inhibidores de la farnesil proteína transferasa útiles como agentes contra el cáncer
SE0202463D0 (sv) Novel compounds
EA200500018A1 (ru) Бензконденсированные гетероариламидные производные тиенопиридинов, применяемые в качестве терапевтических агентов, фармацевтические композиции, включающие их, и способы их применения
HUP0302487A2 (hu) Új mandulasavszármazékok és felhasználásuk trombin inhibitorokként, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
DK0794949T3 (da) Hidtil ukendte 3,5-dioxo-(2H,4H)-1,2,4-triazinderivater, fremstilling heraf og deres anvendelse som lægemidler
NO20050666L (no) 2,7-substituerte indoler og deres anvendelse som 5-HT6 modulatorer
NO20052074L (no) Substituerte benzoksazinoner og anvendelser derav.
EA200500174A1 (ru) Новые производные бензимидазола, полезные в качестве антипролиферативных агентов
DK1753723T3 (da) Substituerede quinolinderivater som mitotiske kinesininhibitorer
TW200607808A (en) Pyrido-pyrimidine derivatives, preparation thereof and application thereof
HUP0302193A2 (hu) 1,4-Diazabiciklo[3.2.2]nonán-benzoxazol,-benzotiazol és -benzimidazol-származékok, előállításuk és ezeket tartalmazó gyógyszerkészítmények
EE200000472A (et) Kasvajavastased toimeained
EA200600570A1 (ru) Замещенные 2-карбониламино-6-пиперидинаминопиридины и замещенные 1-карбониламино-3-пиперидинаминобензолы как агонисты 5-ht
DK1165544T3 (da) Substituerede 1,4-dihydroindeno[1,2-c]pyrazoler som inhibitorer af tyrosinkinase
ATE308540T1 (de) Antithrombosemittel
EA200101230A1 (ru) Новые ингибиторы металлопротеаз, метод их получения и содержащие их фармацевтические композиции
NO20062307L (no) Spirofuropyridinarylderivater
PT982305E (pt) Novos derivados do indano-1-ol proceso para a sua preparacao e as composicoes farmaceuticas que os contem
DK1301475T3 (da) Arylsulfonamider, som serotoninantagonist til behandling af obesitet
SE0100344D0 (sv) New Use